葛蘭素史克GSK
紐約證券 · USD
48.88
+0.47
(+0.97%)
收盤 12/12 04:59 (UTC+8)
盤後
48.89
+0.01
(+0.02%)
12/12 04:59 (UTC+8)
葛蘭素史克GSK
48.88
+0.47
(+0.97%)
財務數據
損益表
- 71.78
- 81.47
- 80.52
- 73.63
- 78.84
- 80.12
- 81.17
- 75.16
- 79.86
- 85.47
- 3.27
- 13.50
- -1.17
- -8.56
- 7.08
- 1.62
- 1.31
- -7.40
- 6.25
- 7.02
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 8,547,000 | 7,986,000 | 7,516,000 | 8,117,000 | 8,012,000 | 7,884,000 | 7,363,000 | 8,052,000 | 8,147,000 | 7,178,000 |
營業成本 | 2,258,000 | 2,165,000 | 1,937,000 | 2,559,000 | 2,397,000 | 2,122,000 | 1,970,000 | 2,418,000 | 2,272,000 | 1,932,000 |
營業毛利 | 6,289,000 | 5,821,000 | 5,579,000 | 5,558,000 | 5,615,000 | 5,762,000 | 5,393,000 | 5,634,000 | 5,875,000 | 5,246,000 |
營業費用 | 3,696,000 | 3,798,000 | 3,363,000 | 3,341,000 | 5,426,000 | 4,116,000 | 3,903,000 | 4,461,000 | 3,926,000 | 3,105,000 |
研發費用 | 1,689,000 | 2,024,000 | 1,462,000 | 2,031,000 | 1,459,000 | 1,477,000 | 1,434,000 | 2,047,000 | 1,575,000 | 1,341,000 |
推銷及管理費用 | 2,239,000 | 2,140,000 | 2,070,000 | 2,663,000 | 3,800,000 | 2,465,000 | 2,087,000 | 2,678,000 | 2,296,000 | 2,268,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | 11,000 | -1,177,000 | 335,000 | 318,000 | 533,000 | - | 367,000 | - |
營業利益 | 2,593,000 | 2,023,000 | 2,216,000 | 2,217,000 | 189,000 | 1,646,000 | 1,490,000 | 1,173,000 | 1,949,000 | 2,141,000 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 167,000 | 184,000 | 162,000 | 144,000 | 156,000 | 174,000 | 166,000 | 155,000 | 182,000 | 185,000 |
稅前純益 | 2,456,000 | 1,887,000 | 2,108,000 | 563,000 | 64,000 | 1,495,000 | 1,355,000 | 379,000 | 1,791,000 | 1,987,000 |
所得稅 | 312,000 | 241,000 | 336,000 | 62,000 | -1,000 | 191,000 | 274,000 | -19,000 | 257,000 | 242,000 |
稅後純益 | 2,013,000 | 1,443,000 | 1,624,000 | 414,000 | -58,000 | 1,173,000 | 1,046,000 | 350,000 | 1,464,000 | 1,624,000 |
基本每股稅後盈餘(元) | 1.00 | 0.71 | 0.79 | 0.20 | -0.03 | 0.58 | 0.51 | 0.17 | 0.72 | 0.64 |
稀釋每股稅後盈餘(元) | 0.98 | 0.70 | 0.79 | 0.20 | -0.03 | 0.57 | 0.51 | 0.17 | 0.71 | 0.64 |
基本平均股數(千股) | 2017000.00 | 2031500.00 | 2044000.00 | 2040500.00 | 2040000.00 | 2039500.00 | 2034500.00 | 2028000.00 | 2027500.00 | 2533125.00 |
稀釋平均股數(千股) | 2051000.00 | 2055000.00 | 2068500.00 | 2072500.00 | 2070500.00 | 2061000.00 | 2056500.00 | 2058000.00 | 2056000.00 | 2558125.00 |
還原基本每股稅後盈餘(元) | 1.00 | 0.71 | 0.79 | 0.20 | -0.03 | 0.58 | 0.51 | 0.17 | 0.72 | 0.64 |
還原稀釋每股稅後盈餘(元) | 0.98 | 0.70 | 0.79 | 0.20 | -0.03 | 0.57 | 0.51 | 0.17 | 0.71 | 0.64 |
還原基本平均股數(千股) | 2,017,000 | 2,031,500 | 2,044,000 | 2,040,500 | 2,040,000 | 2,039,500 | 2,034,500 | 2,028,000 | 2,027,500 | 2,533,125 |
還原稀釋平均股數(千股) | 2,051,000 | 2,055,000 | 2,068,500 | 2,072,500 | 2,070,500 | 2,061,000 | 2,056,500 | 2,058,000 | 2,056,000 | 2,558,125 |
EBITDA(千元) | 2,492,000 | 1,868,000 | 2,122,000 | 620,000 | 97,000 | 1,538,000 | 1,486,000 | 486,000 | 1,903,000 | 2,051,000 |